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Introduction: Most experienced pancreatologists and pancreatic
surgeons recommend resection for even moderately suspicious
cystic lesions in the body and tail of the pancreas, and for
highly suspicious lesions in the head of the gland in developed
countries. We describe three cases with pancreatic tuberculosis
mimicking cystic neoplasm on imaging.
Cases description: A patient presented with fever, bad general
condition and a pancreatic solid-cystic mass in CT-scan, diag-
nosed as pancreatic carcinoma. Second patient, who had back
pain, and a pancreatic cyst at the pancreas body, clinically di-
agnosed as pancreas simple cyst. Third patient a 25 years lady
presented with abdominal pain and weight loss and cystic lesion
at the head of the pancreas. Endoscopic ultrasound guided ﬁne
needle aspiration (EUS-FNA) was done for all cases. All patients
underwent anti-Tb therapy.
EUS-FNA showed caseating granulomatous inﬂammation in these
three cases and acid fast bacilli in one of them. All patients re-
spond to the therapy regimens dramatically both in imaging and
clinics. We emphasize that tuberculosis should now be included
in the differential diagnosis of pancreatic cystic or solid-cystic
masses especially in endemic regions. Diagnostic indicators in-
clude the association of a pancreatic cystic-solid mass with or
without fever, the presence of abdominal pain and a cystic pan-
creatic mass in a younger patient coming from a region where
tuberculosis is endemic.
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Background: To develop protective immunity to Mycobacterium
tuberculosis both latent and active infection, a novel fusion
protein consisting of HspX, the 190 to 198 peptide of Mpt64 and
Ag85B, which are protective antigens expressed in the dormancy
and log phase of growth, respectively, was constructed and its
immunogenicity and efﬁcacy were investigated.
Method: The fusion protein, Ag85B- Mpt64190-198-HspX (AMH)
was constructed,expressed and puriﬁcation. C57BL/6 mice were
immunized three times with AMH formulated in the adjuvant
composed of dimethyl-dioctyldecyl ammonium bromide with
BCG polysaccharide nucleic acid and challenged. Humoral, cell-
mediated immune responses and protection were assayed.
Result: AMH was expressed stably and puriﬁed effectively.Its
vaccine could reduce higher IFN-γand IgG. CFUs, gramulomas
and the degree of acid-fast were lower in lung of AMM+AMH
group.
Conclusion: AMH could induce speciﬁc cellullar and humoral
immune responses and increas the efﬁcacy of AMM vaccine.
PP-202 Costs incurred by TB patients registered in an
urban government DOTS program in Chennai city,
South India
Ramya Ananthakrishnan*,1,2, Anitha Jeyaraj3, G. Palani 3,
B.W.C. Sathiyasekaran3. 1REACH; 2Sree Balaji Medical College
and Hospital; 3Sri Ramachandra Medical College and Hospital
Background: Tuberculosis (TB) patients registered in the govern-
ment clinics under the DOTS (Directly Observed Treatment, Short
course) program in Chennai city, India catering to more than
5 million population between March to June 2007. The present
study was done to estimate the pattern and overall cost incurred
by the patients in the treatment of tuberculosis.
Methods: A cross sectional survey among 300 new TB patients,
who had completed at least 2 months of anti-tuberculosis treat-
ment, was done using a pre-coded semi-quantitative question-
naire.
Results: This study has identiﬁed that each patient on an average
incurred a loss of Rs. 3211.1 ($71.4) which was 3.8% of annual
family income. The direct and indirect costs from the onset of
symptoms to treatment completion were Rs. 1071.4 ($23.8) and
Rs. 2139.7 ($47.6) respectively. Proportion of patients who in-
curred NIL COST for medical, non-medical and indirect costs was
18.3%, 7% and 79.0% before treatment and 97.7%, 58% and 75.3%
in the intensive phase of treatment respectively. The mean total
cost was more for males, age group 15 to 54 years, employed and
extra-pulmonary TB patients. (p value<0.05)
Conclusion: The economic consequences of tuberculosis is con-
siderable especially among extra-pulmonary TB patients, though
the majority proportion of patients incurred costs before treat-
ment.
PP-203 Treatment seeking behavior of TB patients
registered in government DOTS program in
Chennai city, India
Ramya Ananthakrishnan*,1,2, Anitha Jeyaraj3, G. Palani 3,
B.W.C. Sathiyasekaran3. 1REACH, Chennai,India; 2Sree Balaji
Medical College Hospital, Chennai,India; 3Sri Ramachandra
Medical College Hospital, Chennai,India
Background: Tuberculosis (TB) patients registered in govern-
ment clinics under urban DOTS (Direct Observed Treatment,
